Gheibi S, Najmeddin F, Shahrami B, Sadeghi K, Mojtahedzadeh M. The Controversies Surrounding Tocilizumab Administration Following Pathogen-Associated Molecular Pattern (PAMP) Induced by COVID-19. J Pharm Care. 2020;8(3):140-142.